In vivo phage display and vascular heterogeneity: implications for targeted medicine

Overview of attention for article published in Current Opinion in Chemical Biology, June 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial…

Grant US-10786550-B2

United States of America

29 Sep 2020

Metastasis-specific peptides and their diagnostic and therapeutic applications

Grant US-8779092-B2

United States of America

15 Jul 2014

Antibody targeting compounds

Application EP-2428226-A1

European Patent Office

14 Mar 2012

BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND…

Application WO-2012000906-A1

World Intellectual Property Organisation (WIPO)

05 Jan 2012

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.